How can Natera improve the accuracy of its Panorama non-invasive prenatal test for detecting chromosomal abnormalities?

Introduction

To improve the accuracy of Natera's Panorama non-invasive prenatal test for detecting chromosomal abnormalities, we need to take a comprehensive approach that considers technological advancements, user experience, and market dynamics. I'll outline a strategic plan to address this challenge, focusing on key stakeholders and critical pain points.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking about the current accuracy rates of the Panorama test. Could you share the current false positive and false negative rates for the most common chromosomal abnormalities detected?

Why it matters: Establishes a baseline for improvement and helps identify which specific abnormalities need the most attention. Expected answer: False positive rate of 0.1% and false negative rate of 1-2% for common trisomies. Impact on approach: Would focus on reducing false negatives for rarer conditions if common trisomies are already highly accurate.

• Considering user behavior, I'm curious about the typical patient journey. At what stage of pregnancy are most women taking the Panorama test, and how does this timing impact the test's effectiveness?

Why it matters: Helps understand if there's an optimal window for testing that could improve accuracy. Expected answer: Most women take the test between 10-14 weeks of pregnancy. Impact on approach: Might explore ways to encourage earlier testing if it proves more accurate.

• Thinking about external factors, how has the competitive landscape evolved recently? Are there new technologies or methods that competitors are using to improve their test accuracy?

Why it matters: Identifies potential areas for innovation and ensures our solution keeps Natera competitive. Expected answer: Competitors are exploring AI and machine learning to enhance data analysis. Impact on approach: Would consider integrating advanced data analytics into our improvement strategy.

• Regarding company alignment, what are Natera's broader objectives beyond improving test accuracy? Are there specific growth targets or new markets you're aiming to enter?

Why it matters: Ensures our solution aligns with overall company strategy and potentially addresses multiple goals. Expected answer: Natera aims to expand into new geographic markets and increase market share in existing ones. Impact on approach: Would consider how accuracy improvements could be leveraged for market expansion.